Quantification of serum hepatitis C virus core protein level in patients chronically infected with different hepatitis C virus genotypes

Gut

Volumn 39, Issue 6, 1996, Pages 876-880

  Orito, E ^a   Mizokami, M ^a   Tanaka, T ^b   Lau, J Y N ^c   Suzuki, K ^a   Yamauchi, M ^a   Ohta, Y ^d   Hasegawa, A ^e   Tanaka, S ^b   Kohara, M ^f  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d International Reagents Corporation   (Japan)

^e Research and Development Laboratory   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

bDNA; fluorescent enzyme immunoassay (FEIA); HCV core protein; HCV genotype; HCV viraemia

Indexed keywords

ALPHA INTERFERON; DNA;

ADULT; AGED; ARTICLE; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS INFECTION;

EID: 8044242347     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.39.6.876     Document Type: Article

References (18)

1. Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 1-3.
2. Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Nad Acad Sci USA 1991; 88: 2451-5.
3. Kaito M, Watanabe S, Tsukiyama-Kohara K, Yamaguchi K, Kobayashi Y, Konishi M, et al. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994; 75: 1755-60.
4. Kuo G, Choo Q-L, Alter HJ, Gitnick GL, Redeker AG, Purcel RH, et al. An assay for circulating antibodies to a major etiological virus of human non-A, non-B hepatitis. Science 1989; 244: 362-4.
5. Van der Poel VCL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, DiNello R, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317-9.
6. Okamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-noncoding region. Jpn J Exp Med 1990; 60: 215-22.
7. Lau JYN, Davis GL, Knniffen J, Qian KP, Urdea MS, Chan CS, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341: 1501-4.
8. Kaneko S, Murakami S, Unoura M, Kobayashi K. Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction. J Med Virol 1992; 37: 278-82.
9. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 1993; 18: 16-20.
10. Yoshioka K, Kakumu S, Wakita T, Itoh Y, Takayanagi M, Higashi Y, et al. Detection of hepatitis C virus by polymerase chain reaction and response to interferon alfa therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992; 16: 293-9.
11. Orito E, Mizokami M, Nakano T, Terashima H, Nojiri O, Sakakibara K, et al. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C. J Med Virol 1994; 44: 410-4.
12. Collins ML, Zayati C, Detmer JJ, Daly B, Kolberg JA, Cha TA, et al. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem 1995; 226: 120-9.
13. Lau JYN, Simmonds P, Urdea MS. Implications of variations of "conserved" regions of hepatitis C virus genome. Lancet 1995; 346: 425-6.
14. Tanaka T, Lau JYN, Mizokami M, Orito E, Tanaka E, Koyosawa K, et al. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C verimia. J Hepatol 1995; 23: 742-5.
15. Davis GL, Lau JYN, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, et al. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994; 19: 1337-41.
16. Tanaka T, Tsukiyama-Kohara K, Yamaguchi K, Yagi S, Tanaka S, Hasegawa A, et al. Significance of specific antibody assay for genotyping of hepatatis C virus. Hepatology 1994; 19: 1347-53.
17. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 1321-4.
18. Lau JYN, Mizokami M, Kolberg JA, Davis GL, Prescott LE, Ohno T, et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis 1995; 171: 281-9.